Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up

Margherita Branca, A. R. Garbuglia, A. Benedetto, T. Cappiello, L. Leoncini, G. Migliore, A. Agarossi, K. Syrjänen

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

As part of an extensive multi-institutional DIANAIDS study focused on assessing the risk factors, natural history, diagnosis and follow-up of genital human papillomavirus (HPV) infections in HIV-infected women, the present communication reports a sub-cohort of 142 women (89 HIV + and 48 HIV-), followed-up for a mean of 14.07 (± 10.84) months to analyse the factors predicting the persistence and clearance of HPV infections (polymerase chain reaction [PCR] and sequencing) and cervical Papanicolaou (PAP) smear abnormalities, using both univariate (Kaplan-Meier) and multivariate (Cox) survival analysis. The appearance of new HPV infections during the follow-up was significantly more frequent in HIV-positive than in HIV-negative women, odds ratio (OR) 8.800 (95% confidence interval [CI]: 1.199-64.611), and also the clearance rate was significantly less frequent in HIV-positive than in HIV-negative women, 69.2% vs 22.8%, respectively (OR 0.330; 95% CI: 0.163-0.670). These two groups were also markedly different with respect to the clinical course of the cervical lesions, in the frequency of progressive disease (determined by PAP smear) was higher in HIV-positive group (12/89) than in HIV-negative women (2/52) (OR 3.506; 95% CI 0.816-15.055) (P=0.055), in whom the disease regressed more frequently than in HIV-positive women (13.5% vs 7.9%) (OR 0.584; 95% CI 0.217-1.573). Using (1) HPV-positivity, (2) oncogenic HPV-type and (3) significant PAP smear abnormality at the end of follow-up as outcome measures, (1) was significantly (P

Original languageEnglish
Pages (from-to)417-425
Number of pages9
JournalInternational Journal of STD and AIDS
Volume14
Issue number6
DOIs
Publication statusPublished - Jun 1 2003

Fingerprint

Papanicolaou Test
Papillomavirus Infections
HIV
Odds Ratio
Confidence Intervals
Vaginal Smears
Survival Analysis
Natural History
Statistical Factor Analysis
Outcome Assessment (Health Care)

Keywords

  • Clearance
  • HIV-infection
  • HPV sequencing
  • HPV testing
  • PAP smear
  • PCR
  • Persistence
  • Prospective follow-up

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Immunology

Cite this

Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. / Branca, Margherita; Garbuglia, A. R.; Benedetto, A.; Cappiello, T.; Leoncini, L.; Migliore, G.; Agarossi, A.; Syrjänen, K.

In: International Journal of STD and AIDS, Vol. 14, No. 6, 01.06.2003, p. 417-425.

Research output: Contribution to journalArticle

Branca, Margherita ; Garbuglia, A. R. ; Benedetto, A. ; Cappiello, T. ; Leoncini, L. ; Migliore, G. ; Agarossi, A. ; Syrjänen, K. / Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. In: International Journal of STD and AIDS. 2003 ; Vol. 14, No. 6. pp. 417-425.
@article{1816a9e3ab63408e9b4fde89712be007,
title = "Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up",
abstract = "As part of an extensive multi-institutional DIANAIDS study focused on assessing the risk factors, natural history, diagnosis and follow-up of genital human papillomavirus (HPV) infections in HIV-infected women, the present communication reports a sub-cohort of 142 women (89 HIV + and 48 HIV-), followed-up for a mean of 14.07 (± 10.84) months to analyse the factors predicting the persistence and clearance of HPV infections (polymerase chain reaction [PCR] and sequencing) and cervical Papanicolaou (PAP) smear abnormalities, using both univariate (Kaplan-Meier) and multivariate (Cox) survival analysis. The appearance of new HPV infections during the follow-up was significantly more frequent in HIV-positive than in HIV-negative women, odds ratio (OR) 8.800 (95{\%} confidence interval [CI]: 1.199-64.611), and also the clearance rate was significantly less frequent in HIV-positive than in HIV-negative women, 69.2{\%} vs 22.8{\%}, respectively (OR 0.330; 95{\%} CI: 0.163-0.670). These two groups were also markedly different with respect to the clinical course of the cervical lesions, in the frequency of progressive disease (determined by PAP smear) was higher in HIV-positive group (12/89) than in HIV-negative women (2/52) (OR 3.506; 95{\%} CI 0.816-15.055) (P=0.055), in whom the disease regressed more frequently than in HIV-positive women (13.5{\%} vs 7.9{\%}) (OR 0.584; 95{\%} CI 0.217-1.573). Using (1) HPV-positivity, (2) oncogenic HPV-type and (3) significant PAP smear abnormality at the end of follow-up as outcome measures, (1) was significantly (P",
keywords = "Clearance, HIV-infection, HPV sequencing, HPV testing, PAP smear, PCR, Persistence, Prospective follow-up",
author = "Margherita Branca and Garbuglia, {A. R.} and A. Benedetto and T. Cappiello and L. Leoncini and G. Migliore and A. Agarossi and K. Syrj{\"a}nen",
year = "2003",
month = "6",
day = "1",
doi = "10.1258/095646203765371321",
language = "English",
volume = "14",
pages = "417--425",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up

AU - Branca, Margherita

AU - Garbuglia, A. R.

AU - Benedetto, A.

AU - Cappiello, T.

AU - Leoncini, L.

AU - Migliore, G.

AU - Agarossi, A.

AU - Syrjänen, K.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - As part of an extensive multi-institutional DIANAIDS study focused on assessing the risk factors, natural history, diagnosis and follow-up of genital human papillomavirus (HPV) infections in HIV-infected women, the present communication reports a sub-cohort of 142 women (89 HIV + and 48 HIV-), followed-up for a mean of 14.07 (± 10.84) months to analyse the factors predicting the persistence and clearance of HPV infections (polymerase chain reaction [PCR] and sequencing) and cervical Papanicolaou (PAP) smear abnormalities, using both univariate (Kaplan-Meier) and multivariate (Cox) survival analysis. The appearance of new HPV infections during the follow-up was significantly more frequent in HIV-positive than in HIV-negative women, odds ratio (OR) 8.800 (95% confidence interval [CI]: 1.199-64.611), and also the clearance rate was significantly less frequent in HIV-positive than in HIV-negative women, 69.2% vs 22.8%, respectively (OR 0.330; 95% CI: 0.163-0.670). These two groups were also markedly different with respect to the clinical course of the cervical lesions, in the frequency of progressive disease (determined by PAP smear) was higher in HIV-positive group (12/89) than in HIV-negative women (2/52) (OR 3.506; 95% CI 0.816-15.055) (P=0.055), in whom the disease regressed more frequently than in HIV-positive women (13.5% vs 7.9%) (OR 0.584; 95% CI 0.217-1.573). Using (1) HPV-positivity, (2) oncogenic HPV-type and (3) significant PAP smear abnormality at the end of follow-up as outcome measures, (1) was significantly (P

AB - As part of an extensive multi-institutional DIANAIDS study focused on assessing the risk factors, natural history, diagnosis and follow-up of genital human papillomavirus (HPV) infections in HIV-infected women, the present communication reports a sub-cohort of 142 women (89 HIV + and 48 HIV-), followed-up for a mean of 14.07 (± 10.84) months to analyse the factors predicting the persistence and clearance of HPV infections (polymerase chain reaction [PCR] and sequencing) and cervical Papanicolaou (PAP) smear abnormalities, using both univariate (Kaplan-Meier) and multivariate (Cox) survival analysis. The appearance of new HPV infections during the follow-up was significantly more frequent in HIV-positive than in HIV-negative women, odds ratio (OR) 8.800 (95% confidence interval [CI]: 1.199-64.611), and also the clearance rate was significantly less frequent in HIV-positive than in HIV-negative women, 69.2% vs 22.8%, respectively (OR 0.330; 95% CI: 0.163-0.670). These two groups were also markedly different with respect to the clinical course of the cervical lesions, in the frequency of progressive disease (determined by PAP smear) was higher in HIV-positive group (12/89) than in HIV-negative women (2/52) (OR 3.506; 95% CI 0.816-15.055) (P=0.055), in whom the disease regressed more frequently than in HIV-positive women (13.5% vs 7.9%) (OR 0.584; 95% CI 0.217-1.573). Using (1) HPV-positivity, (2) oncogenic HPV-type and (3) significant PAP smear abnormality at the end of follow-up as outcome measures, (1) was significantly (P

KW - Clearance

KW - HIV-infection

KW - HPV sequencing

KW - HPV testing

KW - PAP smear

KW - PCR

KW - Persistence

KW - Prospective follow-up

UR - http://www.scopus.com/inward/record.url?scp=0038726332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038726332&partnerID=8YFLogxK

U2 - 10.1258/095646203765371321

DO - 10.1258/095646203765371321

M3 - Article

VL - 14

SP - 417

EP - 425

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 6

ER -